Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for Chronic Hepatitis B in Adults

NCT06777173 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT06777173
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06777173 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for Chronic Hepatitis B in Adults
Lead sponsor
Beijing Ditan Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
December 1, 2023
Completion date
November 1, 2026
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b, immunotherapy